Erasca to Present at Upcoming Investor Conferences
Location: InterContinental Hotel,
Format: Fireside Chat
Date and Time: Tuesday, November 12,
Location: The Waldorf Hilton,
Format: Presentation
Date and Time: Wednesday, November 20,
7th Annual
Location: Loews Coral Gables Hotel,
Format: Fireside Chat
Date and Time: Wednesday, December 4,
A live audio webcast of the events will be available online at Erasca.com/events. An archived replay of the events will be available for 90 days following the webcast at Erasca.com/events.
About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled one of the deepest RAS/MAPK pathway-focused pipeline in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.
Contact:
jallaire@lifesciadvisors.com
Source: Erasca, Inc.
Source: Erasca, Inc.